Computational approaches to decipher splicing regulatory network of the RON proto-oncogene

Alternative splicing (AS) is a co- or post-transcriptional process by which one gene gives rise to multiple isoforms. This ‘split and combine’ step multiplies eukaryotic proteome diversity several fold and is implicated in several diseases given its pervasive impact. Control of alternative splicing is brought about by cis-regulatory elements, such as RNA sequence and structure, which recruit trans-acting RNA-binding proteins (RBPs). Although several of these interactions are already described in detail, we lack a comprehensive understanding of the regulatory code that underlies a splicing decision. Here, we have established a high-throughput screen to comprehensively identify and characterise cis-regulatory elements that control a specific splicing decision. A cancer-relevant splicing event in proto-oncogene RON was picked as a minigene prototype for initialising the screening approach. Then, we transfected a library of thousands of randomly mutagenised minigene variants as a pool into human cells, and subsequently quantified the spliced isoforms by RNA sequencing. Importantly, we used a barcode sequence to tag the minigene variants and thereby linked mutations to their corresponding spliced products. By using a linear regression-based modelling approach, we were able to determine the effects of single mutations on RON AS. In total, more than 700 mutations were found to significantly affect the splicing regulation of the RON alternative exon. In addition, mutation effects quantified from the screening approach correlate with RON alternative splicing in cancer patients. We discovered numerous previously unknown cis-regulatory elements in both introns and exons, and found that the RBP heterogeneous nuclear ribonucleoprotein H (HNRNPH) extensively regulates RON AS at multiple levels in both cell lines and cancer. Furthermore, the large number of RBPs involved in the process, point to a complex splicing regulatory network involved in the control of RON splicing. iCLIP and synergy analysis between mutations and HNRNPH knockdown data pinpointed the most relevant HNRNPH binding sites across RON. Finally, cooperative HNRNPH binding was shown to mediate a splicing switch of RON alternative exon. In summary, our results provide an unprecedented view on the complexity of splicing regulation of an alternative exon. The novel screening approach introduces a tool to study the relationship of RNA sequence variants along with trans-acting regulators to their impact on the splicing outcome, offering insights on alternative splicing regulation and the relevance of mutations in human disease

New Developments and Possibilities in Reanalysis and Reinterpretation of Whole Exome Sequencing Datasets for Unsolved Rare Diseases Using Machine Learning Approaches

Rare diseases impact the lives of 300 million people in the world. Rapid advances in bioinformatics and genomic technologies have enabled the discovery of causes of 20–30% of rare diseases. However, most rare diseases have remained as unsolved enigmas to date. Newer tools and availability of high throughput sequencing data have enabled the reanalysis of previously undiagnosed patients. In this review, we have systematically compiled the latest developments in the discovery of the genetic causes of rare diseases using machine learning methods. Importantly, we have detailed methods available to reanalyze existing whole exome sequencing data of unsolved rare diseases. We have identified different reanalysis methodologies to solve problems associated with sequence alterations/mutations, variation re-annotation, protein stability, splice isoform malfunctions and oligogenic analysis. In addition, we give an overview of new developments in the field of rare disease research using whole genome sequencing data and other omics

SRSF3 and SRSF7 modulate 3'UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels.

BACKGROUND Alternative polyadenylation (APA) refers to the regulated selection of polyadenylation sites (PASs) in transcripts, which determines the length of their 3' untranslated regions (3'UTRs). We have recently shown that SRSF3 and SRSF7, two closely related SR proteins, connect APA with mRNA export. The mechanism underlying APA regulation by SRSF3 and SRSF7 remained unknown. RESULTS Here we combine iCLIP and 3'-end sequencing and find that SRSF3 and SRSF7 bind upstream of proximal PASs (pPASs), but they exert opposite effects on 3'UTR length. SRSF7 enhances pPAS usage in a concentration-dependent but splicing-independent manner by recruiting the cleavage factor FIP1, generating short 3'UTRs. Protein domains unique to SRSF7, which are absent from SRSF3, contribute to FIP1 recruitment. In contrast, SRSF3 promotes distal PAS (dPAS) usage and hence long 3'UTRs directly by counteracting SRSF7, but also indirectly by maintaining high levels of cleavage factor Im (CFIm) via alternative splicing. Upon SRSF3 depletion, CFIm levels decrease and 3'UTRs are shortened. The indirect SRSF3 targets are particularly sensitive to low CFIm levels, because here CFIm serves a dual function; it enhances dPAS and inhibits pPAS usage by binding immediately downstream and assembling unproductive cleavage complexes, which together promotes long 3'UTRs. CONCLUSIONS We demonstrate that SRSF3 and SRSF7 are direct modulators of pPAS usage and show how small differences in the domain architecture of SR proteins can confer opposite effects on pPAS regulation

SRSF3 and SRSF7 modulate 3′UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels

Background: Alternative polyadenylation (APA) refers to the regulated selection of polyadenylation sites (PASs) in transcripts, which determines the length of their 3′ untranslated regions (3′UTRs). We have recently shown that SRSF3 and SRSF7, two closely related SR proteins, connect APA with mRNA export. The mechanism underlying APA regulation by SRSF3 and SRSF7 remained unknown. Results: Here we combine iCLIP and 3′-end sequencing and find that SRSF3 and SRSF7 bind upstream of proximal PASs (pPASs), but they exert opposite effects on 3′UTR length. SRSF7 enhances pPAS usage in a concentration-dependent but splicing-independent manner by recruiting the cleavage factor FIP1, generating short 3′UTRs. Protein domains unique to SRSF7, which are absent from SRSF3, contribute to FIP1 recruitment. In contrast, SRSF3 promotes distal PAS (dPAS) usage and hence long 3′UTRs directly by counteracting SRSF7, but also indirectly by maintaining high levels of cleavage factor Im (CFIm) via alternative splicing. Upon SRSF3 depletion, CFIm levels decrease and 3′UTRs are shortened. The indirect SRSF3 targets are particularly sensitive to low CFIm levels, because here CFIm serves a dual function; it enhances dPAS and inhibits pPAS usage by binding immediately downstream and assembling unproductive cleavage complexes, which together promotes long 3′UTRs. Conclusions; We demonstrate that SRSF3 and SRSF7 are direct modulators of pPAS usage and show how small differences in the domain architecture of SR proteins can confer opposite effects on pPAS regulation